Drug intelligence / Profile preview

miR-18b

Development stage
Preclinical
Lead developer
Cpmc Research Institute
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

miR-18b is a microRNA that functions as a tumor suppressor, particularly in melanoma. It is often downregulated in melanoma tissues and cell lines due to promoter hypermethylation. miR-18b exerts its anti-tumor effects by directly targeting the 3' untranslated region (UTR) of the MDM2 oncogene, which leads to the degradation of MDM2 mRNA and reduced protein levels. Since MDM2 is a primary negative regulator of p53, the suppression of MDM2 by miR-18b results in the stabilization and activation of the p53 pathway, inducing the expression of p21 and PUMA while inhibiting anti-apoptotic factors like BCL2 and BCL-XL. Preclinical studies have demonstrated that miR-18b overexpression inhibits cell proliferation, migration, and invasion, induces apoptosis, and reverses the epithelial-to-mesenchymal transition (EMT) in melanoma models.

Other names
hsa-mir-18bhsa-mir18bhsa-mir 18b
02

Targets

TP53 (Cellular Tumor Antigen p53 R175H)MDM2 (Mouse double minute 2 homolog)RUNX1KDM (Histone-lysine demethylases)

Beyond the preview

Go deeper on miR-18b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-18b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call